Your email has been successfully added to our mailing list.

×
-0.000498206456755651 -0.00518134715025903 -0.0112594659226783 0.000597847748106838 -0.0165404543642885 -0.0111598246313271 -0.0233160621761657 -0.022718214428059
Stock impact report

Soleno Therapeutics: 2 New Catalysts To Bring Forth Change For PWS Patients [Seeking Alpha]

Soleno Therapeutics, Inc. (SLNO) 
Last soleno therapeutics, inc. earnings: 5/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview
Company Research Source: Seeking Alpha
Summary Soleno Therapeutics, Inc.'s NDA submission of DCCR for the treatment of patients with PWS accepted by the FDA with Priority Review with a PDUFA date of December 27th of 2024. Before the FDA PDUFA date of DCCR for the treatment of patients with PWS, the FDA plans to hold an advisory panel meeting for this drug. If DCCR is granted U.S. marketing approval, it would be the first approved drug of its kind to target hyperphagia and some other problems associated with PWS. The company had $294.6 million in cash as of June 30th of 2024; Enough cash to fund its operations for at least the next 12 months. Looking for a portfolio of ideas like this one? Members of Biotech Analysis Central get exclusive access to our subscriber-only portfolios. Learn More » ISAREE K TIMMS/iStock via Getty Images The last time I spoke about Soleno Therapeutics, Inc. NASDAQ: SLNO ) it was in a Seeking Alpha article entitled “ Soleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst T Show less Read more
Impact Snapshot
Event Time:
SLNO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SLNO alerts

from News Quantified
Opt-in for
SLNO alerts

from News Quantified